We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Five Methods Evaluated for Constrictive Tuberculous Pericarditis Diagnosis

By LabMedica International staff writers
Posted on 24 May 2022

Constrictive pericarditis is a rare and serious disease that accounts for approximately 0. More...

5%–2% of all heart diseases. It results in decreased pericardial compliance and can severely affect the diastolic filling function of the heart, mainly as a symptom of right heart failure, such as multiple plasma chamber effusions and edema.

Constrictive pericarditis has a poor prognosis, and pericardiectomy is the primary treatment of choice. It has several etiologies, including infection (e.g., tuberculosis [MTB], viral infection, and bacterial infection), malignancy, or radiation therapy. MTB is the most common etiology of constrictive pericarditis in developing countries.

Clinical Diagnosticians at the Zhejiang University School of Medicine (Hangzhou, China) reviewed the case histories of patients with suspected constrictive tuberculous pericarditis (TBP) hospitalized between June 1, 2019 and June 31, 2021, who underwent five tests using pericardial tissue. Fresh, diseased pericardial tissue collected during pericardial dissection was used to perform the five tests. A total of 69 patients were included.

Ground pericardial tissue specimens were centrifuged at 3000 g for approximately 15 minutes. The treated deposits were examined by smear microscopy using Auramine O fluorescent dye and stained with Ziehl–Neelsen for confirmation (AFB). Lowenstein–Jensen solid medium and liquid culture medium BACTEC MGIT 960 Mycobacteria Culture System (BD Diagnostic Systems, Sparks, MD, USA) were used for MTB culture.

The CapitalBio Mycobacterium RT-PCR detection kit (CapitalBio Technology Inc., Beijing, China) provided simultaneous screening of MTB and nontuberculous mycobacteria (NTM) infections. It employs duplex fluorescence RT-PCR and TaqMan probe technology to detect both MTB and NTM infections in one test. The Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) was also included for comparision. Histological sections were subjected to pathological examination and anti-acid staining by an experienced pathology professional.

The investigators reported that the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and AUC of AFB smear were 7.3%, 100.0%, 100.0%, 21.5%, and 0.54, respectively. Those of culture were 23.6%, 100.0%, 100.0%, 25.0%, and 0.62, respectively. Those of Xpert MTB/RIF were 52.7%, 100.0%, 100.0%, 35.0%, and 0.76, respectively. Those of CapitalBio assay were 50.9%, 100.0%, 100.0%, 34.2%, and 0.75, respectively. Those of pathology were 92.7%, 92.9%, 98.1%, 76.5%, and 0.93, respectively.

The authors concluded that the diagnosis of constrictive TBP remains challenging. The validity of AFB smear and MTB culture using pericardial tissues remains low. NAATs can provide diagnostic efficacy for TBP, but the efficacy is moderate. The CapitalBio assay and Xpert MTB/RIF could be considered similar for diagnosing TBP. The role of pathology in the diagnosis of constrictive TBP cannot be ignored, considering that pathology showed the best diagnostic accuracy among the five tests. The diagnostic accuracy of the same test is similar in acute or subacute TBP and chronic TBP. The study was published on April 13, 2022 in the International Journal of Infectious Diseases.

Related Links:
Zhejiang University School of Medicine 
BD Diagnostic Systems
CapitalBio Technology Inc
Cepheid


New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.